Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03552380
Title Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Roberto Pili
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Washington District of Columbia 20057 United States Details
Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field